Malaria News and Research

Latest Malaria News and Research

Clinical study shows new Ebola vaccine stimulates strong immune responses in adults

A clinical trial of a new Ebola vaccine (ChAd3-EBO-Z) that resulted from an unprecedented global consortium assembled at the behest of the World Health Organization has found that it is well tolerated and stimulates strong immune responses in adults in Mali, West Africa and in the US, according to a study published in the latest issue of the journal Lancet Infectious Disease.

19 Nov 2015

WHO: Strong actions needed to address climate change to protect people's health

According to WHO estimates, climate change is already causing tens of thousands of deaths every year - from shifting patterns of disease, from extreme weather events, such as heat-waves and floods, and from the degradation of air quality, food and water supplies, and sanitation.

18 Nov 2015

Rice University study examines variation between blood drops drawn from single fingerprick

When it comes to needles and drawing blood, most patients agree that bigger is not better. But in the first study of its kind, Rice University bioengineers have found results from a single drop of blood are highly variable, and as many as six to nine drops must be combined to achieve consistent results.

18 Nov 2015

New US bipartisan study advocates promoting global health to advance wide range of American interests

A new US bipartisan study advocates promoting global health to both "do the right thing" and advance wide-ranging foreign policy interests.

17 Nov 2015

Less effective drugs can help beat malaria more effectively

Oxford University scientists have found that the more effective way to beat malaria is to use less effective drugs some of the time.

13 Nov 2015

Researchers demonstrate new screening model to identify drug targets for the most lethal strain of malaria

A University of South Florida Center for Global Health & Infectious Diseases Research team has demonstrated a new screening model to classify antimalarial drugs and to identify drug targets for the most lethal strain of malaria, Plasmodium falciparum.

12 Nov 2015

Seven researchers win 2015 Early Career Researcher UK Awards

The UK is a world-leader in breakthrough scientific discoveries, and seven of the early career researchers leading this field have been recognised for their contributions to areas including malaria elimination, securing water supplies for future generations and empowering patients in the management of their own health care.

6 Nov 2015

GHIT Fund invests $10.7 million to fight malaria, TB, leishmaniasis and dengue

The Global Health Innovative Technology Fund, which in the last two years has invested US$43 million to develop innovative tools for fighting diseases worldwide, today announced it is investing $10.7 million at multiple points in the product development pipeline to seek new interventions for malaria, tuberculosis (TB), leishmaniasis and dengue.

5 Nov 2015

Malaria parasite hides undetected in the liver for long time before reawakening to cause disease

Eliminating malaria in the Asia-Pacific could prove more challenging than previously thought, with new research showing that most childhood malaria infections in endemic areas are the result of relapsed, not new, infections.

5 Nov 2015

West African man indicted in $12M anti-malaria fraud scheme

The United States Attorney for the Southern District of New York announced the indictment of a citizen of Burkina Faso for his role in a scheme to procure and distribute approximately two million fraudulent and substandard mosquito nets in the West African nation.

31 Oct 2015

New anti-malarial ‘biobricks' could pave way for easier, cost-effective production of artemisinin drug

Students from Trinity College Dublin have successfully created anti-malarial ‘biobricks', which could pave the way for easier and more cost-effective production of the key drug artemisinin.

31 Oct 2015

President and CEO of Protein Sciences elected as 2015 Fellow of the International Society for Vaccines

Protein Sciences Corporation, the makers of Flublok Influenza Vaccine, announced today that Dr. Manon Cox, President and CEO, was elected as a 2015 Fellow of the International Society for Vaccines (ISV). The ISV is an esteemed organization dedicated to the development, advancement and use of vaccines to prevent and control disease.

30 Oct 2015

WHO report reveals significant reduction in TB deaths, but detection, treatment gaps still exist

The fight against tuberculosis is paying off, with this year’s death rate nearly half of what it was in 1990. Nevertheless, 1.5 million people died from TB in 2014. Most of these deaths could have been prevented, according to the World Health Organization’s Global Tuberculosis Report 2015, which was released today in Washington, DC.

29 Oct 2015

Praziquantel treatment safe for pregnant women after first trimester

A study by Rhode Island Hospital researchers confirmed that a drug used to treat a disease afflicting millions of people in developing countries is safe to give pregnant women following their first trimester. The finding could prove critical to the care of pregnant women and lactating women with schistosomiasis, a disease caused by a parasitic worm, who were denied the drug out of concern for their health and the health of their fetuses.

28 Oct 2015

World Vision's For Every Child campaign impacts lives of more than 22 million people worldwide

In 2010, Christian humanitarian organization World Vision embarked on a campaign to impact 20 million people in poverty around the world.

27 Oct 2015

SAGE recommends pilot implementation of malaria vaccine to protect young children

The World Health Organization’s Strategic Advisory Group of Experts on Immunization (SAGE) recommended pilot projects to understand how to best use a vaccine that protects against malaria in young children.

26 Oct 2015

Rapid, award winning diagnostic tests to be presented at MEDICA

A Bloxham-based company focused on improving the usability, safety and accuracy of rapid diagnostic tests will present its fully integrated AtomoRapid™ product range at MEDICA 2015, the world’s largest medical trade fair.

23 Oct 2015

Researchers reveal why malaria vaccine provides only moderate protection among vaccinated children

Using new, highly sensitive genomic sequencing technology, an international team of researchers has found new biological evidence to help explain why the malaria vaccine candidate RTS,S/AS01 (called RTS,S) provided only moderate protection among vaccinated children during clinical testing.

23 Oct 2015

Researchers use cutting edge genomic methods to explain protective effects of malaria vaccine candidate

An international team led by researchers from the Broad Institute of MIT and Harvard, the Harvard T.H. Chan School of Public Health, and Fred Hutchinson Cancer Research Center have used cutting edge genomic methods to uncover key biological insights that help explain the protective effects of the world's most advanced malaria vaccine candidate, RTS,S/AS01 (RTS,S).

22 Oct 2015

Research finding points towards developing effective malaria vaccine

In a recent breakthrough to combat malaria, a collaboration of Indian and American scientists have identified a malarial parasite protein that can be used to develop antibodies when displayed on novel nanoparticles. This approach has the potential to prevent the parasite from multiplying in the human host and also inhibits transmission through mosquitoes. The finding points towards developing a powerful malaria vaccine in the hope of eradicating this debilitating and often fatal disease.

20 Oct 2015

Malaria News and Research

Latest Malaria News and Research

Clinical study shows new Ebola vaccine stimulates strong immune responses in adults

WHO: Strong actions needed to address climate change to protect people's health

Rice University study examines variation between blood drops drawn from single fingerprick

New US bipartisan study advocates promoting global health to advance wide range of American interests

Less effective drugs can help beat malaria more effectively

Researchers demonstrate new screening model to identify drug targets for the most lethal strain of malaria

Seven researchers win 2015 Early Career Researcher UK Awards

GHIT Fund invests $10.7 million to fight malaria, TB, leishmaniasis and dengue

Malaria parasite hides undetected in the liver for long time before reawakening to cause disease

West African man indicted in $12M anti-malaria fraud scheme

New anti-malarial ‘biobricks' could pave way for easier, cost-effective production of artemisinin drug

President and CEO of Protein Sciences elected as 2015 Fellow of the International Society for Vaccines

WHO report reveals significant reduction in TB deaths, but detection, treatment gaps still exist

Praziquantel treatment safe for pregnant women after first trimester

World Vision's For Every Child campaign impacts lives of more than 22 million people worldwide

SAGE recommends pilot implementation of malaria vaccine to protect young children

Rapid, award winning diagnostic tests to be presented at MEDICA

Researchers reveal why malaria vaccine provides only moderate protection among vaccinated children

Researchers use cutting edge genomic methods to explain protective effects of malaria vaccine candidate

Research finding points towards developing effective malaria vaccine

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Malaria News and Research

Latest Malaria News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in